Repare Therapeutics
A leading precision oncology company focused on synthetic lethality
45 employees · est. 2016 · Montreal, Canada
Ten63 Therapeutics
Explore beyond, leave nothing unseen.
25 employees · est. 2018 · Durham, United States
Repare Therapeutics is the older company (2016 vs 2018).
Side-by-Side Comparison
| Metric | Repare Therapeutics | Ten63 Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2018 |
| Headquarters | ||
| Headquarters | Montreal, Canada | Durham, United States |
| Employees | ||
| Employees | 45 | 25 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Series A |
| Total Funding | ||
| Total Funding | $607.40M | $15.90M |
| Funding Rounds | ||
| Funding Rounds | 8 | 3 |
| Services | ||
| Services | Not tracked yet | Generative chemistry exploration, Quantum-accurate simulations, Virtual CSO - Sentinel, Drug design for intractable diseases |
| Target Customers | ||
| Target Customers | Not tracked yet | Biotechnology companies, Pharmaceutical researchers, Healthcare institutions, Oncology research teams |
| Taxonomy | ||
| Taxonomy | Precision Oncology, Synthetic Lethality, CRISPR-enabled, SNIPRx Platform, Genomic Instability, DNA Damage Repair, Novel Therapeutics, Clinical-stage Development, Cancer Therapies, Genome-wide Discovery, Targeted Cancer Treatment, Drug Discovery, Therapeutics Development, Personalized Medicine | Therapeutics, Cancer Research, Drug Development, In Silico Platform, AI In Healthcare, Precision Medicine, Drug Resistance, Healthtech, Biotech Innovation, Durable Response, Medical Breakthroughs, Innovation In Pharmaceuticals |
| Website | ||
| Website | reparerx.com | ten63tx.com |
About Repare Therapeutics
Repare Therapeutics, founded in 2016, is a prominent player in the precision oncology sector, based in Canada. The company utilizes a proprietary synthetic lethality approach to develop innovative cancer therapies. Their SNIPRx® platform, powered by genome-wide CRISPR technology, targets genomic ins...
About Ten63 Therapeutics
Ten63 Therapeutics, founded in 2018 and based in the United States, is at the forefront of the Biotechnology, Health Care, and Pharmaceutical industries. The company is committed to revolutionizing human health by developing therapeutics that target cancer and other severe diseases. Utilizing their...
We will tell you when either one moves
BounceWatch watches Repare Therapeutics and Ten63 Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Repare Therapeutics and Ten63 Therapeutics — by email.
Frequently Asked Questions
Compare Repare Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Repare Therapeutics on 15 Jun 2026, and Ten63 Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
